Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • SGLT
    (3)
Filter
Search Result
Results for "

rsglt2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Inhibitors_Agonists
Canagliflozin
TA 7284, JNJ 28431754AAA, JNJ 28431754, JNJ 24831754ZAE
T1782842133-18-0
Canagliflozin (JNJ 28431754AAA) is a selective SGLT2 inhibitor that inhibits CHO cells expressing mSGLT2, rSGLT2, and hSGLT2 (IC50=2 3.7 4.4 nM). Canagliflozin can be used for the treatment of type II diabetes mellitus (T2DM).
  • Inquiry Price
Size
QTY
Remogliflozin etabonate
GSK189075, GSK 189075, GSK-189075A, GSK189075A, GSK-189075, GSK 189075A
T34286442201-24-3
Remogliflozin etabonate (GSK189075A) is a prodrug of regaliflozin and an inhibitor SGLT2 with Ki values of 1.95, 2.14, 8.57, and 43.1μM for hSGLT2, rSGLT2, rSGLT1, and hSGLT1, respectively.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
Canagliflozin hemihydrate
JNJ28431754, TA 7284, TA7284, TA-7284, JNJ 28431754, JNJ-28431754
T1782L928672-86-0
Canagliflozin hemihydrate (TA 7284) is a drug of the gliflozin class or subtype 2 sodium-glucose transport inhibitors used for the treatment of type 2 diabetes. SGLT2 is responsible for at least 90% of renal glucose reabsorption (SGLT1 being responsible for the remaining 10%). Blocking this transporter causes up to 119 grams of blood glucose per day to be eliminated through the urine, corresponding to 476 kilocalories.
  • Inquiry Price
7-10 days
Size
QTY